Ukuhlolwa Okusha Komtholampilo Okudabukisayo Kokucindezeleka Okuhlobene Nomdlavuza

I-Enveric Biosciences isebenza ne-University of Calgary's Hotchkiss Brain Institute, isikhungo esihamba phambili se-neuroscience of excellence, e-Cumming School of Medicine eCalgary, eCanada esizinikele ekuthuthukiseni ucwaningo lobuchopho nempilo yengqondo kanye nemfundo, ukusungula isilingo somtholampilo esivusa amadlingozi. I-EVM-101 yokwelashwa kwe-Cancer Related Distress.

Cishe u-50% weziguli ezinomdlavuza zibika amazinga omtholampilo okucindezeleka kwengqondo anesimo sokucindezeleka, ukukhathazeka, ukudangala, ukubonakaliswa komtholampilo okubangelwa ingcindezi, kanye nezinga lempilo elinciphile. Kufika ku-40% weziguli ezinomdlavuza zihlangabezana nemibandela yokuphazamiseka kwemizwa okudinga ukwelashwa. I-CRD iyisidingo esibalulekile sezokwelapha esingahlangabeziwe esingenayo imvume yokulawula yamanje yemithi yokwelapha kanye nesidingo esiphuthumayo sokuthuthukisa izinga lamanje lokunakekelwa kweziguli ezinomdlavuza.

Ukuhlolwa komtholampilo, okulindeleke ukuthi kwethulwe kamuva kulo nyaka, kwe-EVM-101, ukwelashwa kwengqondo yesizukulwane sokuqala, kwe-CRD kuzoholwa umcwaningi we-HBI, uDkt. Valerie Taylor, iNhloko yoMnyango Wezengqondo, eCalgary, eCanada. 

“Sijabule ukusebenzisana ne-Enveric ukuze sifunde ngemithi yesizukulwane esilandelayo esethemba ukuthi izosiza abantu ukuthi babhekane nezinselelo zempilo yengqondo zokuxilongwa komdlavuza. Lo msebenzi uzosivumela ukuthi sihlanganise izinsiza zethu ezihlangene ukuze senze ucwaningo ngeziguli ezinomdlavuza eziphila ne-CRD,” kusho uDkt. Valerie Taylor.

Ucwaningo lwe-EVM-101 luzohlola ngokuqondile izici eziyinhloko ze-CRD ezithinteka kakhulu futhi ezivumayo ukuba ngcono kulandela ukwelashwa okusekelwe ku-psilocybin.

“Ngokwenyuka kwamazinga omdlavuza kanye nezifo ezihambisana nawo ezingokwengqondo ebezibukelwa phansi futhi zingaxilongwa kuze kube muva nje, sisebenza kanzima ukuthuthukisa izindlela zokwelapha ezintsha ezisiza iziguli ezinomdlavuza eziphethwe yi-CRD” kusho uDkt. Bob Dagher, Isikhulu Esiyinhloko Sezokwelapha sika-Enveric. “Ukubambisana kwethu nethimba labacwaningi eNyuvesi yaseCalgary’s Hotchkiss Brain Institute kanye ne-IMPACT Clinical Trial Accelerator kuzosisiza ukuthi sibonise izinzuzo ezingaba khona zalezi zindlela zokwelapha ezisanda kuzalwa futhi zizenze zimakethwe ngokushesha okukhulu.”

Ukuhanjiswa okusemthethweni kwaHealth Canada kulindeleke ukuthi kuphothulwe maduze. Ukubhaliswa kwesiguli ocwaningweni lomtholampilo kulindeleke ukuthi kuqale ngasekupheleni kuka-2022 noma ngasekuqaleni kuka-2023. Idizayini yocwaningo izosebenzisa ukwelapha kwengqondo okusemthethweni kanye nokwelashwa kwengqondo ezigulini ezinomdlavuza ezine-CRD. Iziguli zizothola umthamo womlomo owodwa we-EVM-101 endaweni esekelayo nge-psychotherapy ukuze kuthuthukiswe imiphumela.